SPRO vs ZS · P/E 9.6, rev $258.0K vs rev $3.35B
Spero Therapeutics Inc (SPRO) versus Zscaler Inc (ZS) — a side-by-side from cached financials, not a winner call.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Zscaler Inc (ZS) is a software - infrastructure company listed on US. It is led by Jagtar Singh Chaudhry.
Latest reported SPRO revenue for 2026-06-30 was $258.0K. Net income was -$16.8M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Latest reported ZS revenue for 2026-07-31 was $3.35B. Net income was -$63.2M. Revenue was up 25.4% from 2025-07-31 to 2026-07-31. ZS currently screens at market cap $49.01B.
SPRO currently screens at market cap $149.5M and trailing P/E 9.6. ZS currently screens at market cap $49.01B.
Not investment advice. Open the SPRO and ZS stock pages for the full models.
Not investment advice.